Skip to content

Usability Study of ArmAssist 2.0. Robot: Homecare Arm Rehabilitation in Stroke Patients

Usability Study of ArmAssist 2.0. Robot: Homecare Arm Rehabilitation in Acute, Subacute and Chronic Stroke Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04405609
Acronym
PUAA
Enrollment
9
Registered
2020-05-28
Start date
2019-10-28
Completion date
2019-12-30
Last updated
2020-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rehabilitation, Robot-assisted Therapy, Stroke, Telerehabilitation, Upper Limb Rehabilitation

Keywords

Stroke, Cerebrovascular Disorders, Robotic

Brief summary

The purpose of this study is to validate the usability of ArmAssist medical device, a robotic system for the rehabilitation of upper limbs in stroke patients (based on serious games). This study evaluate the usability of the system in a home environment, taking into account the ease-to-use, consistency and others; and will pretend demonstrate the feasibility of including or no, robotic therapy in home like complement of daily rehabilitation program. Finally this study investigate the acceptance from patients and therapists.

Interventions

DEVICEArmAssist

The usability study protocol include 3 ArmAssist systems (2 designed for the left hand and one for the right hand) that could not be used in parallel because the aim of the study was to bring the systems to the home environment during part of the evaluation. The usability study is carried out in two phases: 1. First phase: 5 weeks. 2. Second phase: 3 weeks. Each phase included a week of training at the Hospital or IMIBIC facilities with a physiotherapist, and then 2 weeks at the patient's home, being the first one with the physiotherapist supervision and the second one by their own with the possibility of physiotherapist remote support.

Sponsors

TECNALIA Research & Innovation
CollaboratorUNKNOWN
GMV Innovating Solutions
CollaboratorUNKNOWN
Maimónides Biomedical Research Institute of Córdoba
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects over 18, * Upper limb hemiparesis after stroke, * Unilateral paresis and cognitive ability to understand, * Accept and actively participate in the usability study.

Exclusion criteria

* Bilateral motor deficit, * Severe spasticity, * Psychiatric illness, * and/or cognitive impairment.

Design outcomes

Primary

MeasureTime frameDescription
System Usability Scale: SUSThrough study completion, an average of 3 weeksThis scale provides a quick, reliable tool for measuring the usability. It consists of 10 item questionnaire and answers from 1 'strongly agree' to 5 'strongly disagree'. Scores are ranging to 0-100 %, where a high score means better usability with a higher score meaning better usability
Usability questionnaire specifically designed for the use of ArmAssist 2.0Through study completion, an average of 3 weeksIt consists of a 19 item questionnaire with seven response options (Likert sacle) for respondents; from Strongly agree to Strongly disagree. To evaluate the satisfaction of patients and therapist with the system and the therapy.
Structured interviews: Willingness-to-pay questionnaireThrough study completion, an average of 3 weeksThis interview consists in two short questions to ask to participants about the willingness-to-pay for ArmAssist 2.0. system as therapy.
Quebec User Evaluation of Satisfaction with assistive Technology: QUEST scaleThrough study completion, an average of 3 weeksThe purpose of this scale is to evaluate how satisfied the patient are with the assistive device and the related services they experienced. It consists of twelve questions, eight related to the device and four related to services of 12 satisfaction items with answers from 1 'Not satisfied at all' to 5 'Very satisfied'
Intrinsic Motivation Inventory: IMIThrough study completion, an average of 3 weeksThis scale is a multidimensional scale intended to assess participants subjective experience with the device (interest/enjoyment, perceived competence, effort, value/usefulness, felt pressure and tension, and perceived choice while performing a given activity). Consist of 20 item questionnaire with answers from 1 'strongly agree' to 7 'strongly disagree'.

Secondary

MeasureTime frameDescription
Modified Asworth Scale (MAS)Baseline, 3 weeksThis scale measures resistance during passive soft-tissue stretching and is used as a simple measure of spasticity. It is single-item measures ranging from 0 to 4, where 0 indicates no increase in muscle tone and 4 indicates that the affected part is rigid in flexion or extension.
Fugl-Meyer Assessment (FMA) scaleBaseline, 3 weeksIt is an index to assess the sensorimotor impairment in individuals who have had stroke. The Fugl-Meyer Assessment scale is an ordinal scale that has 3 points for each item. A zero score is given for the item if the subject cannot do the task. A score of 1 is given when the task is performed partially and a score of 2 is given when the task is performed fully. The maximun score is 66 points

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026